C6
protein-codingcomplement C6, the group of Sushi domain containing|Complement system activation components
Gene summary
This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause cell lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~119.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012908
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012908
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Antiinfectious prophylaxis (including related to specific immunization) and early and aggressive treatment of infections may be beneficial
Comments: Antiinfectious prophylaxis (including related to specific immunization strategies) and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to C6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000065.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 2 | 148 | 1 | 152 | |
| missense | 289 | 24 | 6 | 319 | ||
| nonsense | 15 | 11 | 26 | |||
| start loss | 1 | 1 | ||||
| frameshift | 17 | 15 | 32 | |||
| splice donor/acceptor (+/-2bp) | 13 | 13 | ||||
| Total | 32 | 40 | 292 | 172 | 7 | 543 |
Highest pathogenic variant AF is 0.0028107413
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000056.2 | 17 | MANE Select | |
| Ensembl | ENSP00000338861.5 | 17 | MANE Select | |
| RefSeq | NP_001108603.2 | 17 | Standard | |
| Ensembl | ENSP00000263413.3 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Prion diseases - Homo sapiens (human)
- Complement and coagulation cascades - Homo sapiens (human)
- Systemic lupus erythematosus - Homo sapiens (human)
- Allograft Rejection
- Human Complement System
Biological Process
- in utero embryonic development
- positive regulation of activation of membrane attack complex
- complement activation
- complement activation, classical pathway
- cytolysis
Molecular Function
- protein binding
Cellular Component
- extracellular region
- membrane attack complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000263413
- Coding exons
- 17
- Length
- 119205
- Individuals with no LoFs
- 124585
- Homozygous LoFs
- 4
- Heterozygous LoFs
- 1153
- Defined
- 125742
- p
- 0.00461
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.877 | 535 | 481 | 1.11 | 0.0000249 | 6128 |
| Missense (PolyPhen) | 165 | 167.1 | 0.98744 | 2112 | ||
| Synonymous | -2.83 | 221 | 174 | 1.27 | 0.00000900 | 1696 |
| Loss of Function | 1.59 | 40 | 52.5 | 0.763 | 0.00000287 | 637 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.020 | 0.020 | notable |
| Latino/Admixed American | 0.0029 | 0.0029 | notable |
| Ashkenazi Jewish | 0.0020 | 0.0020 | notable |
| East Asian | 0.0026 | 0.0026 | notable |
| Finnish | 0.0016 | 0.0016 | notable |
| European (Non-Finnish) | 0.0043 | 0.0043 | notable |
| South Asian | 0.0039 | 0.0039 | notable |
| Other | 0.0049 | 0.0049 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells.;
- Disease
- DISEASE: Complement component 6 deficiency (C6D) [MIM:612446]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. {ECO:0000269|PubMed:15565285}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.273
- RVIS EVS
- 1.32
- RVIS percentile EVS
- 94.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.547
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |